The role of KRAS and NRAS mutation detection in determining the therapy strategy for colorectal cancer
Colorectal cancer is one of the most frequently diagnosed malignant tumors in men and women, which is a highly heterogeneous group of neoplasms consisting of subclasses with different molecular and clinical characteristics, and, as a consequence, patients with different types of tumors require diffe...
Main Authors: | A. N. Toropovskiy, A. G. Nikitin, D. A. Viktorov, A. V. Solov'ev, R. M. Khuzina, O. N. Pavlova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Private institution educational organization of higher education "Medical University "ReaViz"
2022-11-01
|
Series: | Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье |
Subjects: | |
Online Access: | https://vestnik.reaviz.ru/jour/article/view/536 |
Similar Items
-
INFLUENCE OF SOMATIC MUTATIONS OF KRAS, NRAS, BRAF AND MICROSATELLITE INSTABILITY STATUS ON SURVIVAL OF COLORECTAL CANCER PATIENTS WITH PERITONAL CARCINO
by: V. P. Shubin, et al.
Published: (2020-10-01) -
Mutational profile of KRAS-positive colorectal cancer
by: E. N. Telysheva, et al.
Published: (2022-03-01) -
Molecular-genetic mechanisms of the signal cascade RAS-RAF-MEK-ERK associated with the development of the tumor process and the purpose of targeted drugs for colorectal cancer
by: A. N. Toropovsky, et al.
Published: (2021-08-01) -
EGFR inhibitors in the treatment of colorectal cancer
by: M. В. Zabelin, et al.
Published: (2018-09-01) -
Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
by: Aleksandra Bożyk, et al.
Published: (2021-03-01)